Muscarinic receptor antagonists
US5607950A · kind A · utility
18Cited by
5References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 10, 1994 |
| Grant date | Mar 4, 1997 |
| Priority date | — |
| Expiry date | Feb 10, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/06
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invetion is a method of treating irritable bowel syndrome with a compound selected from the formula ##STR1## wherein R, R.sup.1, m, n p are as defined in the specification, or a pharmaceutically acceptable salt thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.